Filing Details
- Accession Number:
- 0001209191-12-039430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-27 20:20:07
- Reporting Period:
- 2012-07-25
- Filing Date:
- 2012-07-27
- Accepted Time:
- 2012-07-27 20:20:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197018 | Anthony N Coles | C/O Onyx Pharmaceuticals, Inc. 249 East Grand Ave. South San Francisco CA 94080 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-07-25 | 11,883 | $73.97 | 162,853 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold to cover a tax obligation realized by the reporting person that arose in connection with the vesting of stock awards granted to the reporting person under the Issuer's 2005 Equity Incentive Plan.
- Includes 406 shares purchased through the issuer's employee stock purchase plan on June 29, 2012.
Billionaire Hedge Funds
